Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 19 Mar 2017 Status changed from recruiting to completed according to results presented at the 66th Annual Scientific Session of the American College of Cardiology.
- 04 Mar 2015 New trial record